Detection and management of vascular hypertension

Comprehensive Ophthalmology Update

Volumn 8, Issue 3, 2007, Pages 145-151

  Grosso, Andrea ^a,b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NONE   (Italy)

Author keywords

Biomarker; Early retinopathy signs; Pre hypertension; Retinal imaging; Retinal vascular signs

Indexed keywords

DISEASE SEVERITY; HUMAN; HYPERTENSION RETINOPATHY; MICROCIRCULATION; MORTALITY; OPHTHALMOSCOPY; PRACTICE GUIDELINE; RETINA INJURY; REVIEW;

HUMANS; HYPERTENSION; OPHTHALMOLOGY; PRACTICE GUIDELINES; PROGNOSIS; RETINAL DISEASES; RETINAL VESSELS;

EID: 34547644453     PISSN: 15277313     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Oparil S, Zaman MA, Calhoun DA: Pathogenesis of hypertension. Ann Intern Med 139: 761-76, 2003
2. Taddei S, Virdis A, Ghiadoni L, et al: Endothelial dysfunction in hypertension. J Nephrol 13: 205-10, 2000
3. Wong TY, Mitchell P: Hypertensive retinopathy. N Engl J Med 351: 2310-7, 2004
4. Antonios TF, Singer DR, Markandu ND, et al: Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 34: 655-8, 1999
5. Noon JP, Walker BR, Webb DJ, et al: Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 99: 1873-9, 1997
6. Hulthén UL, Bolli P, Kiowski W, et al: Inhibition of the arteriolar smooth muscle NA+ -K+-pump induces an enhanced vasoconstriction in borderline but not in established essential hypertension. Gen Pharmacol 14: 193-6, 1983
7. Delles C, Michelson G, Harazny J, et al: Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke 35: 1289-93, 2004
8. Grosso A, Veglio F, Porta M, et al: Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol 89: 1646-54, 2005
9. Nørrelund H, Christensen KL, Samani NJ, et al: Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 24: 301-8, 1994
10. Smeda JS, Lee RM, Forrest JB: Structural and reactivity alterations of the renal vasculature of spontaneously hypertensive rats prior to and during established hypertension. Circ Res 63: 518-33, 1988
11. le Noble JL, Tangelder GJ, Slaaf DW, et al: A functional morphometric study of the cremaster muscle microcirculation in young spontaneously hypertensive rats. J Hypertens 8: 741-8, 1990
12. Suzuma I, Hata Y, Clermont A, et al: Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 50: 444-54, 2001
13. Staessen JA, Wang J, Bianchi G, et al: Essential hypertension. Lancet 361: 1629-41, 2003
14. Ziegler MG, Mills P, Dimsdale JE: Hypertensives' pressor response to norepinephrine. Analysis by infusion rate and plasma levels. Am J Hypertens 4: 586-91, 1991
15. Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: their course and prognosis. Am J Med Sci 268: 336-45, 1974
16. Anderson EA, Sinkey CA, Lawton WJ, et al: Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 14: 177-83, 1989
17. Schlaich MP, Lambert E, Kaye DM, et al: Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension 43: 169-75, 2004
18. Gorelick PB: New horizons for stroke prevention: PROGRESS and HOPE. Lancet Neurol 1: 149-56, 2002
19. Rumantir MS, Kaye DM, Jennings GL, et al: Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 36: 824-9, 2000
20. Wong TY, Klein R, Sharrett AR, et al: Retinal arteriolar diameter and risk for hypertension. Ann Intern Med 140: 248-55, 2004
21. Wong TY: Fred Hollows lecture: hypertensive retinopathy - a journey from fundoscopy to digital imaging. Clin Experiment Ophthalmol 34: 397-400, 2006
22. van den Born BJ, Hulsman CA, Hoekstra JB, et al: Value of routine funduscopy in patients with hypertension: systematic review. BMJ 331: 73, 2005
23. Wong TY, Knudtson MD, Klein R, et al: Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 111: 1183-90, 2004
24. Patton N, Aslam TM, MacGillivray T, et al: Retinal image analysis: concepts, applications and potential. Prog Retin Eye Res 25: 99-127, 2006
25. Hughes AD, Martinez-Perez E, Jabbar AS, et al: Quantification of topological changes in retinal vascular architecture in essential and malignant hypertension. J Hypertens 24: 889-94, 2006
26. Nguyen TT, Wong TY: Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 17: 262-8, 2006
27. Cooper ME, Tikellis C, Thomas MC: Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system. J Hypertens Suppl 24: S57-63, 2006
28. Wong TY, Islam FM, Klein R, et al: Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci 47: 2341-50, 2006
29. Klein R, Klein BE, Knudtson MD, et al: Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. Arch Ophthalmol 124: 87-94, 2006
30. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-72, 2003
31. _: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011-53, 2003
32. Tso MO, Jampol LM: Pathophysiology of hypertensive retinopathy. Ophthalmology 89: 1132-45, 1982
33. Ikram MK, Witteman JC, Vingerling JR, et al: Retinal vessel diameters and risk of hypertension: the Rotterdam Study. Hypertension 47: 189-94, 2006
34. Liew G, Sharrett AR, Kronmal R, et al: Measurement of retinal vascular caliber: issues and alternatives to using the arteriole to venule ratio. Invest Ophthalmol Vis Sci 48: 52-7, 2007
35. Patton N, Aslam T, Macgillivray T, et al: Asymmetry of retinal arteriolar branch widths at junctions affects ability of formulae to predict trunk arteriolar widths. Invest Ophthalmol Vis Sci 47: 1329-33, 2006
36. Wong TY, Shankar A, Klein R, et al: Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165: 1060-5, 2005
37. Wong TY, Klein R, Sharrett AR, et al: Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288: 67-74, 2002
38. Mitchell P, Wang JJ, Wong TY, et al: Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 65: 1005-9, 2005
39. Wong TY, Klein R, Sharrett AR, et al: Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA 287: 1153-9, 2002
40. Wong T, Mitchell P: The eye in hypertension. Lancet 369: 425-35, 2007
41. Wong TY, Klein R, Sharrett AR, et al: Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 33: 1487-92, 2002
42. Klein R, Klein BE, Moss SE, Wong TY: The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc 104: 98-107, 2006
43. Wong TY, Mohamed Q, Klein R, et al: Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes?. Br J Ophthalmol 90: 301-3, 2006
44. Ohkubo T, Kikuya M, Metoki H, et al: Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 46: 508-15, 2005
45. Pickering TG, Shimbo D, Haas D: Ambulatory blood-pressure monitoring. N Engl J Med 354: 2368-74, 2006
46. Zhang Y, Lee ET, Devereux RB, et al: Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 47: 410-4, 2006
47. Comer RM, Dawson E, Plant G, et al: Causes and outcomes for patients presenting with diplopia to an eye casualty department. Eye 21: 413-8, 2007
48. Wong TY, Larsen EK, Klein R, et al: Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology 112: 540-7, 2005
49. Cuspidi C, Ambrosioni E, Mancia G, et al: Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens 20: 1307-14, 2002
50. Wong TY, McIntosh R: Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 73-74: 57-70, 2005
51. Grosso A, Rabbia F, Fea A, et al: Comparison between generalized retinal arteriolar narrowing and left ventricular mass in young untreated hypertensive patients. Blood Press 15: 308-12, 2006
52. Ahmed J, Ward TP, Bursell SE, et al: The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes Care 29: 2205-9, 2006
53. Trento M, Passera P, Borgo E, et al: A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. Diabetes Care 27: 670-5, 2004
54. Trento M, Passera P, Miselli V, et al: Evaluation of the locus of control in patients with type 2 diabetes after long-term management by group care. Diabetes Metab 32: 77-81, 2006
55. _: Annual meeting of the Psychoneuroimmunology Research Society. Utrecht, The Netherlands. May 16-20, 2001. Abstracts. Brain Behav Immun 15: 115-98, 2001
56. Camici PG, Crea F: Coronary microvascular dysfunction. N Engl J Med 356: 830-40, 2007
57. Wang TJ, Gona P, Larson MG, et al: Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355: 2631-9, 2006